期刊： SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2022; 39 (2)
Background: The differential diagnosis of nontuberculous mycobacteria (NTM) lung disease, active tuberculosis (ATB) and multi-drug resistant tuberculo......
期刊： SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2022; 39 (2)
Objective: Anthracosis is defined as deposition of black pigments in the bronchial mucosa or lung parenchyma. The aim of this study was to investigate......
期刊： SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2019; 36 (3)
Background: Pulmonary sarcoidosis patients who get disease progression despite corticosteroid treatment or can't tolerate corticosteroid required seco......
期刊： SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2018; 35 (2)
Background: The association between NOD2/CARD15 (nucleotide binding oligomerisation domain containing 2) gene polymorphisms and susceptibility to sarc......
期刊： SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2018; 35 (4)
Background: Pulmonary alveolar proteinosis (PAP) is a rare interstitial lung disease classified into congenital form, autoimmune form and secondary fo......
期刊： SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2017; 34 (1)
A 32-year-old woman was diagnosed as pulmonary tuberculosis 15 years ago and recurred several times due to long-term nonstandard treatment. Drug sensi......
期刊： SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2017; 34 (3)
Objective: To characterize and compare the disease manifestations between patients with sarcoidosis in China versus the United States using the World ......
